학술논문
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Document Type
Article
Author
Source
In The Lancet 2007 370(9605):2103-2111
Subject
Language
ISSN
0140-6736